Advisors Preferred, LLC Belite Bio, Inc Transaction History
Advisors Preferred, LLC
- $602 Million
- Q4 2024
A detailed history of Advisors Preferred, LLC transactions in Belite Bio, Inc stock. As of the latest transaction made, Advisors Preferred, LLC holds 798 shares of BLTE stock, worth $46,315. This represents 0.01% of its overall portfolio holdings.
Number of Shares
798Holding current value
$46,315% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BLTE
# of Institutions
18Shares Held
80.3KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.1KShares$1.17 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC13.5KShares$780,6960.0% of portfolio
-
Marshall Wace, LLP London, X08.49KShares$492,5270.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.7KShares$388,8680.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.46KShares$374,9380.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.44B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...